Clay Thorp

Insider Reports History

Location
Durham, NC
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Clay Thorp:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vigil Neuroscience, Inc. Director Common Stock 1,556,030 $5,835,113 $3.75 17 May 2022 By Hatteras Venture Partners VI, L.P.
Clearside Biomedical, Inc. Director Common Stock 176,141 $162,050 $0.9200 24 Feb 2025 Direct
Vigil Neuroscience, Inc. Director Common Stock 3,000 $11,250 $3.75 16 May 2022 Direct
PhaseBio Pharmaceuticals Inc Director Common Stock 3,545,040 19 May 2023 Indirect
Clearside Biomedical, Inc. Director Stock Option (right to buy) 45,000 20 Jun 2024 Direct
PhaseBio Pharmaceuticals Inc Director Common Stock 36,693 19 May 2023 Direct
PhaseBio Pharmaceuticals Inc Director Restricted Stock Units 0 19 May 2023 Direct

Insider Reports Filed by Clay Thorp

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CLSD Clearside Biomedical, Inc. 24 Feb 2025 1 +$13,800 4 Director 24 Feb 2025, 17:52
CLSD Clearside Biomedical, Inc. 20 Jun 2024 1 $0 4 Director 21 Jun 2024, 16:15
CLSD Clearside Biomedical, Inc. 25 Sep 2023 1 +$8,600 4 Director 25 Sep 2023, 16:34
CLSD Clearside Biomedical, Inc. 22 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:41
/report/000116924523000032-thorp-clay-2023-05-19 PhaseBio Pharmaceuticals Inc 19 May 2023 2 $0 4 Director 19 May 2023, 16:18
CLSD Clearside Biomedical, Inc. 21 Dec 2022 1 +$14,266 4 Director 21 Dec 2022, 15:26
CLSD Clearside Biomedical, Inc. 15 Dec 2022 2 $0 4 Director 19 Dec 2022, 18:41
CLSD Clearside Biomedical, Inc. 22 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:21
/report/000116924522000065-thorp-clay-2022-05-19 PhaseBio Pharmaceuticals Inc 19 May 2022 2 $0 4 Director 20 May 2022, 16:46
VIGL Vigil Neuroscience, Inc. 16 May 2022 2 +$104,411 4 Director 17 May 2022, 21:06
VIGL Vigil Neuroscience, Inc. 28 Mar 2022 1 +$21,604 4 Director 28 Mar 2022, 16:44
VIGL Vigil Neuroscience, Inc. 11 Jan 2022 4 +$3,710,000 4 Director 11 Jan 2022, 20:20
VIGL Vigil Neuroscience, Inc. 06 Jan 2022 0 $0 3 Director 06 Jan 2022, 19:34
/report/000116924521000080-thorp-clay-2021-08-18 PhaseBio Pharmaceuticals Inc 18 Aug 2021 1 +$30,000 4 Director 18 Aug 2021, 18:07
CLSD Clearside Biomedical, Inc. 10 Jun 2021 1 $0 4 Director 11 Jun 2021, 17:33
/report/000116924521000059-thorp-clay-2021-06-03 PhaseBio Pharmaceuticals Inc 03 Jun 2021 1 $0 4 Director 04 Jun 2021, 18:03
CLSD Clearside Biomedical, Inc. 10 Feb 2021 1 -$145,627 4/A Director 19 Dec 2022, 18:40